Biotech

All Articles

Novartis sparks brand new phase of Voyager deal along with $15M capsid offer

.Novartis is opening a new frontier in its cooperation with Voyager Rehabs, spending $15 million to ...

Lilly blog posts much more favorable information on its own every week the hormone insulin prospect

.On the heels of an FDA denial for its own primary rivalrous Novo Nordisk, Eli Lilly is actually pul...

IN 8bio stops phase 2 trial, lays off fifty percent of workforce

.Only a handful of months after dosing the first person in a period 2 trial for freshly detected gli...

Lilly, Haya ink $1B biobuck obesity deal to look black genome

.Eli Lilly's look for excessive weight intendeds has actually led it to the darker genome. The Big P...

ArsenalBio raises $325M, pivots off of former lead resource

.Collection Biosciences is actually carrying on up. The tissue treatment provider has added on $325 ...

Lilly- backed fat burning biotech reports IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' marijuana usage medicine flunks stage 2b, driving Indivior to reassess $100M possibility

.Aelis Farma's hopes of getting a fast, positive choice on a $100 million possibility remittance hav...

ProKidney halts period 3 trial not needed for tissue therapy permission

.ProKidney has quit among a set of stage 3 trials for its cell therapy for renal illness after deter...

Vaxcyte climbs on 'sensational' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what experts named "impressive" phase 1/2 information for its 31-valent pneumococc...

Recursion's brain health condition trial reveals little evidence of efficiency

.Recursion has stumbled via a very early exam of its tech-enabled strategy to medicine revelation, r...